Clinical Trials Browser

Terminated × Lung Neoplasms × tanespimycin × Clear all

NCT01228435 2017-12-04

IPI-504 in NSCLC Patients With ALK Translocations

Phase 2 Terminated

3 enrolled 5 charts

Lung Neoplasms